Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy

Journal of Hepatology

Volumn 27, Issue 6, 1997, Pages 1029-1040

  Meng, Ling Jie ^a   Reyes, Humberto ^b   Palma, Jonquin ^b   Hernandez, Ismael ^b   Ribalta, José ^b   Sjövall, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Bile acids; Chromatography; Glucuronides; Intrahepatic cholestasis of pregnancy; Mass spectrometry; N acetylglucosaminides; Progesterone metabolites; Serum; Sulphates; Urine; Ursodeoxycholic acid

Indexed keywords

5ALPHA PREGNANE 3ALPHA,20ALPHA DIOL; BILE ACID CONJUGATE; CHENODEOXYCHOLIC ACID; CHOLIC ACID; GLUCURONIDE; N ACETYLGLUCOSAMINE; PROGESTERONE; URSODEOXYCHOLIC ACID;

ADULT; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BILE ACID BLOOD LEVEL; CLINICAL ARTICLE; CONJUGATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG HYDROXYLATION; DRUG MECHANISM; DRUG METABOLISM; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; FEMALE; HUMAN; INTRAHEPATIC CHOLESTASIS; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE METABOLISM; URINARY EXCRETION;

EID: 0030734641     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80147-X     Document Type: Article

References (56)

1. Sjövall K, Sjövall J. Serum bile acid levels in pregnancy with pruritus. Clin Chim Acta. 13:1966;207-211.
2. Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O. Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur J Obstet Gyn R B. 14:1983;153-162.
3. Bacq Y, Myara A, Brechot M-C, Hamon C, Studer E, Trivin F, et al. Serum conjugated bile acid profile during intrahepatic cholestasis of pregnancy. J Hepatol. 22:1995;66-70.
4. Thomassen PA. Urinary bile acids during development of recurrent cholestasis of pregnancy. Eur J Clin Invest. 9:1979;417-423.
5. Thomassen PA. Urinary bile acids in late pregnancy and in recurrent cholestasis of pregnancy. Eur J Clin Invest. 9:1979;425-432.
6. Sjövall J, Sjövall K. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels. Ann Clin Res. 2:1970;231-337.
7. Eriksson H, Gustafsson J-Å, Sjövall K. Excretion of neutral steroids in urine and faeces of women with intrahepatic cholestasis fo pregnancy. Steroids Lipids Res. 3:1972;30-48.
8. Laatikainen T, Karjalainen O, Jänne O. Excretion of progesterone metabolites in urine and bile of pregnant women in intrahepatic cholestasis. J Steroid Biochem. 4:1973;461-468.
9. Giusti G, Piccinino F, Ricciardi I, Delrio G, Sagnelli E, Manzillo G. Abnormal steroid sulphates in plasma of women with intrahepatic cholestasis of pregnancy. Acta Hepato-Gastroenterol. 26:1979;203-206.
10. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzales MC, Hernandez I, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology. 15:1992;1043-1047.
11. Meng LJ, Reyes H, Palma I, Hernandez I, Ribalta J, Sjövall J. Profiles of steroids and bile acids in plasma of patients with intrahepatic cholestasis of pregnancy - effect of ursodeoxycholic acid therapy. van Berge Henegouwen GP, van Hoek B, Groote J, Matern S, Stochbrügger RW. Cholestatic Liver Diseases. 1994;45-49 Kluwer Academic Publishers, Dordrecht.
12. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval S, Almuna R, et al. Ursodeoxycholic acid therapy in choletasis of pregnancy. Reyes HB, Leuschner U, Arias IM. Pregnancy, Sex Hormones and the Liver. 1995;223-227 Kluwer Academic Publishers, Dordrecht/Boston/London.
13. Meng LJ, Sjövall J. Method for combined analysis of profiles of conjugated progesterone metabolites and bile acids in serum and urine of pregnant women. J Chromatogr B Biomed Appl. 688:1997;11-26.
14. Marschall HU, Matern H, Wietholtz H, Egestad B, Matern S, Sjovall J. Bile acid N-Acetylglucosaminidation - in vivo and in vitro evidence for a selective conjugation reaction of 7β-hydroxylated bile acids in humans. J Clin Invest. 89:1992;1981-1987.
15. Meng LJ, Reyes H, Palma I, Hernandez I, Ribalta J, Sjövall J. Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J Hepatol. 1997;. in press.
16. Meng LJ, Griffiths WJ, Sjövall J. The identification of novel steroid N-acetyglucosaminides in the urine of pregnant women. J Steroid Biochem Mol Biol. 58:1996;585-598.
17. Jänne OA, Vihko RK. Neutral steroids in urine during pregnancy. Identification of sulphate-conjugated 3β,15α-dihydroxy-5α-pregnan-20-one, 3β,15α-dihydroxy-5β- pregnan-20-one and 5-pregnene-3β,15β,17α,20α-tetrol. Eur J Biochem. 17:1970;134-140.
18. Kraan GP, Wolthers BG, van der Molen JC, Nagel GT, Drayer NM, Joannou GE. The identified 15β-hydroxylated 21-deoxy-pregnanes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Steroid Biochem Mol Biol. 45:1993;421-434.
19. Eriksson H, Gustafsson J-Å. Excretion of steroid hormones in adults: steroids in urine from a pregnant woman. Eur J Biochem. 16:1970;268-277.
20. Sjövall K. Gas chromatographic determination of steroid sulphates in plasma during pregnancy. Ann Clin Res. 2:1970;393-408.
21. Tikkanen MJ, Pulkkinen MO, Adlercreutz H. Effect of ampicillin treatment on the urinary excretion of estriol conjugates in pregnancy. J Steroid Biochem. 4:1973;439-440.
22. Adlecreutz H, Martin F, Tikkanen MJ, Pulkkinen M. Effect of ampicillin administration on the excretion of twelve oestrogens in pregnancy urine. Acta Endocr Copenh. 80:1975;551-557.
23. Martin F, Peltonen J, Laatikainen T, Pulkkinen M, Adlercreutz H. Excretion of progesterone metabolites and estriol in faeces from pregnant women during ampicilin administration. J Steroid Biochem. 6:1975;1339-1346.
24. Adlercreutz H, Martin F, Lehtinen T, Tikkanen MJ, Pulkkinen MO. Effect of ampicillin administration on plasma conjugated and unconjugated estrogen and progesterone levels in pregnancy. An J Obstet Gynecol. 128:1997;266-271.
25. Marschall HU, Grifiths WJ, Götze U, Zhang J, Wietholtz H, Busch N, et al. The major metabolites of ursodeoxycholic acid in human urine are conjugated with N-acetylglucosamine. Hepatology. 20:1994;845-853.
26. Koopman BJ, Wolthers BG, van der Molen JG, Nagel GT, Kruizinga W. Abnormal urinary bile acids in a patients suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid. Biochim Biophys Acta. 917:1987;238-246.
27. Schteingart CD, Hagey LR, Setchell KDR, Hofmann AF. 5β-Hydroxylatin by the liver: identification of 3,5,7-trihydroxy nor-bile acids as new major biotransformation products of 3,7-dihydroxy nor-bile acids in rodents. J Biol Chem. 268:1993;11239-11246.
28. Sjövall J, Lawson AM, Setchell KDR. Mass spectrometry of bile acids. Meth Enzymol. 111:1985;63-113.
29. Dumaswala R, Setchell KDR, Zimmer-Nechemias L, Iida T, Goto J, Nambara T. Identification of 3α,4β,7α-trihydroxy-5β-cholanoic acid in human bile: reflection of a new pathway in bile acid metabolism in humans. J Lipid Res. 30:1989;847-856.
30. Hofmann AF, Bile acids. Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA. 3rd ed. The Liver: Biology and Pathobiology. 1994;677-718 Raven Press, New York.
31. van Berge Henegouwen GP, Brandt K-H, Eyssen H, Parmentier G. Sulfated and unsulfated bile acids in serum. bile and urine of patients with cholestasis. Gut. 17:1976;861-869.
32. Stiehl A. Disturbances of bile acid metabolism in cholestasis. Clin Gastroenterol. 6:1977;45-67.
33. Back P. Urinary bile acids. Setchell KDR, Kritchevsky D, Nair PP. The Bile Acids: Chemistry, Physiology, and Metabolism. 4:1988;404-440 Plenum Press, New York and London.
34. Hofmann AF. Pharmacology of ursodeoxycholic acid, an exterohepatic drug. Scand J Gastroenterol. 29:1994;1-15. (Suppl).
35. Stieger B, Zhang J, O'Neill B, Sjövall J, Meier PJ. Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters. Eur J Biochem. 244:1997;39-44.
36. 4-3-Oxosteroid 5β-reductase deficiency described in identical twins with neonatal hepatitis. J Clin Invest. 82:1988;2148-2157.
37. 4 bile acids in liver disease. Lancet. i:1988;1283-1284.
38. Beuers U, Throckmorton DC, Anderson MS, Isales CM, Thasler W, Kullak-Ublick GA, et al. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology. 110:1996;1553-1563.
39. ++ mechanisms defective in cholestasis. J Clin Invest. 92:1993;2984-2993.
40. Boyer JL, Soroka CJ. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology. 109:1995;1600-1611.
41. Kreek MJ. Female sex steroids and cholestasis. Semin Liver Dis. 7:1987;8-23.
42. Setchell KD, Dumaswala R, Colombo C, Ronchi M. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J Biol Chem. 263:1988;16637-16644.
43. Nakagawa M, Setchell KDR. Bile acid metabolism in early life: studies of amniotic fluid. J Lipid Res. 31:1990;1089-1098.
44. Strandvik B, Wahlén E, Wikström SA. The urinary bile acid excretion in healthy premature and full-term infants during the neonatal period. Scand J Clin Lab Invest. 54:1994;1-10.
45. Laatikaine TJ, Peltonen JI, Nylander PL. Effect of maternal intrahepatic cholestasis on fetal steroid metabolism. J Clin Invest. 53:1974;1709-1715.
46. Laatikainen T, Karjalainen O. Excretion of conjugates of neutral steroids in human bile during late pregnancy. Acta Endocr Copenh. 60:1972;775-788.
47. 21 steroids in faeces from pregnant women. Eur J Biochem. 12:1969;520-526.
48. Adlecreutz H, Martin F. Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem. 13:1980;231-244.
49. Martin F, Peltonen J, Laatikainen T, Tikkanen M, Pulkkinen M. Exretion of unconjugated and conjugated progesterone metabolites in pregnancy urine during ampicillin administration. Clin Chim Acta. 55:1974;71-80.
50. Anderson RA, Baillie TA, Axelson M, Cronholm T, Sjövall K, Sjövall J. Stable isotrope studies on steroid metabolism and kinetics: sulphates of 3α-hydroxy-5α-pregnane derivatives in human pregnancy. Steroid. 55:1990;443-457.
51. Baillie TA, Curstedt T, Sjövall K, Sjövall J. Production rates and metabolism of sulphates of 3β-hydroxy-5α-pregnance derivatives in pregnant women. J Steroid Biochem. 13:1980;1473-1488.
52. Marschall HU, Griffiths WJ, Zhang J, Wietholtz H, Matern H, Matern S, et al. Positions of conjugation of bile acids with glucose and N-acetylglucosamine in vitro. J Lipid Res. 35:1994;1599-1610.
53. Stiehl A, Rudolph G, Raedsch R, Möller B, Hopf U, Lotterer E, et al. Eusodeoxcyholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology. 12:1990;492-497.
54. Fischer S, Neubrand M, Paumgartner G. Biotransformation of orally administered usrodeoxcycholic acid in man as observed in gallbladder bile, serum and urine. Eur J Clin Invest. 23:1993;28-36.
55. Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatographymass spectrometry: effect of ursodeoxycholic acid treatment. J Lipid Res. 30:1989;1953-1962.
56. Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, et al. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhossis. Hepatology. 10:1989;414-419.